T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding T2 Biosystems, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 21 | 19 | −2 |
| Shares | 218.1K | 173.3K | −44.8K (−20.6%) |
| Value | $1.37M | $519.8K | −$847.9K (−62.0%) |
New holders (2)
Institutions that held T2 Biosystems, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 1,750 | $5.25K | 0.00% |
| Newbridge Financial Services Group, Inc. | 10 | $30 | 0.00% |
Sold out (4)
Institutions that held T2 Biosystems, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 20,572 | $129.0K |
| Jane Street Group, LLC | 15,417 | $96.7K |
| Game Plan Financial Advisors, LLC | 33 | $207 |
| Focused Wealth Management, Inc | 3 | $19 |